Resapp Health : Appendix 3B

Appendix 3B‌‌‌‌

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

New issue announcement, application for quotation of additional securities‌‌‌ and agreement‌

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

RESAPP HEALTH LIMITED

ABN

51 094 468 318

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1	+Class of +securities issued or to be issued	Employee Incentive Options
2	Number of +securities issued or to be issued (if known) or maximum number which may be issued	750,000 Employee Incentive Options
3	Principal terms of the +securities (e.g. if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)	250,000 Options ($0.45; 31 October 2020) pursuant to the terms of the Company's Employee Incentive Plan. 500,000 Options ($0.45; 12 December 2020) pursuant to the terms of the Company's Employee Incentive Plan.

4	Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities? If the additional +securities do not rank equally, please state: the date from which they do the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment	No. Options will convert into Ordinary Shares.
5	Issue price or consideration	Employee Incentive Options issued for nil cash consideration under the Company Employee Incentive Plan.
6	Purpose of the issue (If issued as consideration for the acquisition of assets, clearly identify those assets)	Employee Incentive Options issued to provide an incentive and reward for employees for their contributions to the Company.
6a	Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A? If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i	Yes
6b	The date the security holder resolution under rule 7.1A was passed	2 November 2016
6c	Number of +securities issued without security holder approval under rule 7.1	Nil

+ See chapter 19 for defined terms.

Appendix 3B Page 2 04/03/2013

6d	Number of +securities issued with security holder approval under rule 7.1A	Nil
6e	Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)	Nil
6f	Number of +securities issued under an exception in rule 7.2	750,000 Employee Incentive Options
6g	If +securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation.	Not applicable
6h	If +securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements	Not applicable
6i	Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements	Listing Rule 7.1 - 98,855,940 Listing Rule 7.1A - 65,903,960
7	+Issue dates Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A. Cross reference: item 33 of Appendix 3B.	14 February 2017
Number	+Class
8	Number and +class of all +securities quoted on ASX (including the +securities in section 2 if applicable)	596,602,103	Fully paid ordinary shares

Number

+Class

62,437,499 38,437,500 55,312,500 5,000,000 5,000,000 10,000,000 3,000,000 2,000,000 4,500,000 1,866,667 2,000,000 250,000 500,000 2,000,000 2,000,000 7,200,000 7,400,000

Fully paid ordinary shares (escrowed to 14 July 2017) Performance Shares converting on a 1:1 basis upon the achievement of milestone (escrowed to 14 July 2017) Performance Shares converting on a 1:1 basis upon the achievement of milestone Incentive Options ($0.025; 2 July 2020) Incentive Options ($0.05; 2 July 2020) Incentive Options ($0.10; 2 July 2020) Incentive Options ($0.05; 22 September 2020) Incentive Options ($0.10; 22 September 2020) Unlisted Options ($0.28; 29 April 2019) escrowed for 12 months to 29 April 2017. Unlisted Options ($0.30; 29 April 2019) escrowed for 12 months to 29 April 2017. Employee Incentive Options ($0.45; 16 September 2019) Employee Incentive Options ($0.45; 31 October 2020) Employee Incentive Options ($0.45; 12 December 2020) Consultancy Incentive Options ($0.45; 16 September 2019) Consultancy Incentive Options ($0.75; 16 September 2019) Director Incentive Options ($0.45; 10 November 2019) Director Incentive Options ($0.75; 10 November 2019)

Number and +class of all

+securities not quoted on ASX (including the +securities in section 2 if applicable)

+ See chapter 19 for defined terms.

Appendix 3B Page 4 04/03/2013